AMGN vs DAY · P/E 24, rev $10.05B vs P/E 345, rev $1.76B
Amgen Inc (AMGN) versus Dayforce Inc. (DAY) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Dayforce Inc. (DAY) is a software - application company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported DAY revenue for 2024-12-31 was $1.76B. Net income was $18.1M. Revenue was up 16.3% from 2023-12-31 to 2024-12-31. DAY currently screens at market cap $8.81B and trailing P/E 344.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. DAY currently screens at market cap $8.81B and trailing P/E 344.5.
Not investment advice. Open the AMGN and DAY stock pages for the full models.
Not investment advice.